NK cells play a key role in innate elimination of virally infected or neoplastic cells but they can be circumvented by immunoevasive mechanisms enabling viral spread or tumor progression. Engagement of the NKG2D activating receptor with soluble forms of itsligand is one such mechanism of inducing NK cell hyporesponsiveness. Interestingly, this immunoevasive strategy among others is described at the maternal-fetal interface where tolerance of the semi-allogeneic fetus is required to allow successful human pregnancy. Understanding of maternal-fetal tolerance is increasing but mechanisms preventing alloreactivity of fetal immune cells against the maternal host are less well understood. The study of umbilical cord blood has enabled insight of the fetal immune system, which appears immature and inert. We have found that soluble NKG2D ligands (sNKG2DLs) are present in cord blood plasma (CBP) and associate with adult NK cell hyporesponsiveness demonstrated by reduced CD107a expression and secretion of IFN-γ upon stimulation. The capacity of NK cells to kill K562 cells or proliferate was also reduced by incubation with CBP; however, physical removal of sNKG2DL from CBP restored K562 lytic function and NKG2D expression. Therefore, our results strongly suggest sNKG2DLs are expressed in CBP as a mechanism of fetal-maternal tolerance in human pregnancy.
Keywords:Ligand r NK cell r NKG2D r Pregnancy r Tolerance Additional supporting information may be found in the online version of this article at the publisher's web-site Eur. J. Immunol. 2015Immunol. . 45: 2324Immunol. -2334 Innate immunity 2325 group 2, member D receptor (NKG2D) on infected and tumor cells [4,5]. NKG2D is a C-type lectin-like molecule and interaction with its cognate ligand expressed on stressed cells results in direct cytolysis and cytokine production [6]. Immunoevasive strategies allow some viruses and tumors to escape detection by intracellular retention of NKG2D ligands (NKG2DLs) [7]. Alternatively, soluble NKG2DLs (sNKG2DLs) can be released from the cell surface as free-soluble molecules by protease cleavage or by secretion on exosomes [5]. NKG2D is expressed on NKT cells, γδ + T cells and CD8 + T cells as well as NK cells. Interaction with sNKG2DLs leads to downregulation of this receptor, rendering the cell hyporesponsive [8,9]. There are eight known types of NKG2DLs that divide into two groups; [10,11] the highly polymorphic MHC class Irelated chain A and B (MICA/B) and the unique long 16 binding proteins (ULBP1-6), which are also polymorphic [12][13][14][15]. It is probable that viral and possibly tumor immunity has shaped evolution of NKG2DLs in an effort to combat immunoevasive strategies targeting NKG2D. Human pregnancy presents a unique immunological dilemma as the fetus is semiallogeneic and a potential target for destruction by maternal T cells recognizing paternal antigens on placental trophoblast cells [16]. Maternal T-cell responses against trophoblasts are limited by unusual expression of MHC class I antigens by the various trophoblast...